/agents/services/due-diligence
Regulatory & Technology Due Diligence
BiggsB helps investors and acquirers understand the regulatory, quality and technology risk in a target before they commit. We assess compliance maturity, systems and data integrity, identify issues that affect value or timelines, and provide a practical remediation roadmap.
- Service ID
- due-diligence
- Topic
- regulatory and compliance due diligence for life sciences
- Source page
- https://biggsb.com/services/due-diligence
- Contact
- Discuss this service · connect@biggsb.com
Who it is for
- Private equity and venture investors evaluating life sciences or health technology companies
- Corporate acquirers assessing regulated targets
- Companies preparing for investment that want an independent readiness view
When clients call us
- A transaction is in diligence and regulatory risk is unclear
- A startup's compliance claims need independent assessment
- Post-close integration needs a regulatory and systems plan
Scope
- Regulatory compliance review and gap analysis
- Startup compliance maturity assessment
- Technology and systems assessment, including validation status and data integrity
- Operational due diligence and risk identification
- Integration planning and post-merger regulatory support
Typical deliverables
- Due diligence findings report with risk ratings
- Remediation roadmap with effort estimates
- Investment risk summary for decision makers
- Integration plan for regulated operations and systems
Approach
- 01Scope. Agree the questions that matter for the investment decision and timeline.
- 02Assess. Review documentation, systems and interviews to evidence findings.
- 03Advise. Translate findings into risk, cost and timeline implications.
Boundaries
Our diligence covers regulatory, quality and technology matters and complements, rather than replaces, legal and financial diligence.
Questions about Due Diligence
- Can you assess a startup's regulatory readiness for investors?
- Yes. We assess compliance maturity, identify gaps and estimate the remediation needed, so investors can factor regulatory readiness into the decision.
Next step
Describe your need on the contact page, email connect@biggsb.com, or book a consultation call.